TY - JOUR
T1 - The effect of size and surface ligands of iron oxide nanoparticles on blood compatibility
AU - Liu, Tao
AU - Bai, Ru
AU - Zhou, Huige
AU - Wang, Rongqi
AU - Liu, Jing
AU - Zhao, Yuliang
AU - Chen, Chunying
N1 - Funding Information:
This work was supported by the Ministry of Science and Technology of China (2016YFA0201600 and 2016YFE0133100), the Science Fund for Creative Research Groups of the National Natural Science Foundation of China (11621505), the National Natural Science Foundation of China (31700879, 31900997), the CAS Key Research Program for Frontier Sciences (QYZDJ-SSW-SLH022), the CAS interdisciplinary innovation team, and the National Science Fund for Distinguished Young Scholars (11425520), the Young Elite Scientists Sponsorship Program by Chinese Society of Toxicology.
Publisher Copyright:
© 2020 The Royal Society of Chemistry.
PY - 2020/2/21
Y1 - 2020/2/21
N2 - Superparamagnetic iron oxide nanoparticles (SPIONs) have been widely used and have attracted increased attention for their unique physicochemical properties, especially in biomedical sciences as contrast agents following intravenous administration. However, only few studies have systematically reported the blood compatibility of iron oxide nanoparticles with different physicochemical properties such as different sizes and surface ligands. Therefore, we selected three widely used organic ligands (polyacrylic acid, hyaluronic acid, and chitosan) with modified SPIONs at the same size of 5-6 nm, and polyacrylic acid-modified SPIONs with different sizes (5, 10, and 30 nm) at different concentrations to evaluate their haemocompatibility. Our results revealed that SPIONs modified with polyacrylic acid demonstrated size-dependent destruction of red blood cells and complement activation. Interestingly, 5 nm SPIONs prolonged blood clotting time as compared with 10 nm and 30 nm SPIONs in vitro. Compared with polyacrylic acid-modified SPIONs, hyaluronic acid- and chitosan-modified SPIONs least affected red blood cells, platelets, coagulation, and complement activation. Hence, hyaluronic acid- and chitosan-coated SPIONs are more suitable for nanomedicine applications than polyacrylic acid-coated SPIONs. Furthermore, the interaction between SPIONs and blood components strongly correlated with the administered concentration of nanoparticles. These results will provide some experimental information for safe-by-design SPIONs.
AB - Superparamagnetic iron oxide nanoparticles (SPIONs) have been widely used and have attracted increased attention for their unique physicochemical properties, especially in biomedical sciences as contrast agents following intravenous administration. However, only few studies have systematically reported the blood compatibility of iron oxide nanoparticles with different physicochemical properties such as different sizes and surface ligands. Therefore, we selected three widely used organic ligands (polyacrylic acid, hyaluronic acid, and chitosan) with modified SPIONs at the same size of 5-6 nm, and polyacrylic acid-modified SPIONs with different sizes (5, 10, and 30 nm) at different concentrations to evaluate their haemocompatibility. Our results revealed that SPIONs modified with polyacrylic acid demonstrated size-dependent destruction of red blood cells and complement activation. Interestingly, 5 nm SPIONs prolonged blood clotting time as compared with 10 nm and 30 nm SPIONs in vitro. Compared with polyacrylic acid-modified SPIONs, hyaluronic acid- and chitosan-modified SPIONs least affected red blood cells, platelets, coagulation, and complement activation. Hence, hyaluronic acid- and chitosan-coated SPIONs are more suitable for nanomedicine applications than polyacrylic acid-coated SPIONs. Furthermore, the interaction between SPIONs and blood components strongly correlated with the administered concentration of nanoparticles. These results will provide some experimental information for safe-by-design SPIONs.
UR - http://www.scopus.com/inward/record.url?scp=85081121048&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85081121048&partnerID=8YFLogxK
U2 - 10.1039/c9ra10969b
DO - 10.1039/c9ra10969b
M3 - Article
AN - SCOPUS:85081121048
SN - 2046-2069
VL - 10
SP - 7559
EP - 7569
JO - RSC Advances
JF - RSC Advances
IS - 13
ER -